ACADVL is linked with
very long-chain acyl-coenzyme A dehydrogenase deficiency (VLCADD), which has many symptoms, and typically presents as one of three
phenotypes. The first is severe, with an early childhood onset and high mortality rate; the most common symptom is this form is
cardiomyopathy. The second is a late onset childhood form, with milder symptoms that present most commonly as hypoketotic hypoglycemia. The final form presents in adulthood, and presents as isolated skeletal muscle involvement,
rhabdomyolysis, and
myoglobinuria, which is triggered by exercise or fasting. The disease is typically diagnosed by first performing
tandem mass spectrometry on a blood sample of the patient during a period of stress, and then performing molecular
genetic testing for the presence of the ACADVL gene. The deficiency is treated systematically, but certain conditions such as
fasting, myocardial irritation,
dehydration, and high fat diets are avoided in an attempt to prevent secondary complications. == Interactions ==